The regulation of EMT by the Wnt signaling pathway has been determined including Wnt5a [31], FOXP3 [32], SERPINH1 [33], CUL4B [34], and SUFU [35], which can be used in BLCA, gastric cancer, and pancreatic cancer. This evidence concerns the gene WNT5A and bladder transitional cell carcinoma.